The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFFWD.L Regulatory News (FFWD)

  • There is currently no data for FFWD

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Investee company update

18 Jul 2008 07:00

RNS Number : 3455Z
London Asia Chinese Private Equity
18 July 2008
 



London Asia Chinese Private Equity Fund Limited

("LACPEF")

Investee company signs major new Coal Methane Project

LACPEF (AIM: LCP.L), the China focused investment company, announces that its investee company, Asia Clean Energy Co. Ltd. ("ACE") has entered into a joint venture with USA-based Caterpillar, China's State Power International Finance & Trade Corporation Ltd. and Shanxi Xinhe Energy Co. Ltd. ("the consortium") to develop one of the largest Clean Development Mechanism ("CDM") projects in China. The consortium will develop a 300MW Coal Mine Methane ("CMM") power generation project in China's Shanxi Province. ACE will own 49% of the joint venture company.

CMM or Coal Bed Methane ("CBM") is a hazardous gas that can cause major explosions and accidents if not processed properly. CMM is widely used as an alternative energy source in many parts of the world. China is estimated to have the world's third largest reserve of CMM and plans to increase the amount it uses in the coming years. The Chinese government actively encourages the use of CMM as an alternative energy source and has outlined this in its recently published national 11-5 development plan.

The first phase of the Shanxi project will be the development of an 84MW CMM power generation unit, which is expected to be completed in October 2008.  The total investment for phase one will be US$100 million, consisting of US$33 million in equity and US$66 million of debt.

ACE has made an initial investment of $4.29 million. Once this initial pilot scheme is satisfactorily completed, the consortium will proceed to set up a 300 MW CMM power generation station, with a projected annual coal methane usage of 1.2 billion cubic meters. The methane will be provided by joint venture partner Shanxi Xinhe Energy Co. Ltd., the largest coal mine company in Jing ChengShanxi province.  This project is estimated to be the largest CMM power generation project in China. Phase II and Phase III of the project are expected to be completed in 2011 and 2012. 

Mr. Zhang Kang Zhu, CEO of ACE, said: "We are very excited to launch this consortium with world class partner companies, to develop what will be one of the largest CDM power generation projects to date in China. This project is in line with China's commitment to reduce carbon emissions and develop alternative energy sources, as well as to improve safety at China's mines."

Roy Leighton, Chairman of LACPEF, said: "The returns likely to be generated from this project should have a significant impact on the value of our holding in ACE once the project is fully operational. ACE's ability to win such a prestigious and strategically important project for China, with partners of such calibre, demonstrates further the quality of the management team and underlines the opportunities open to it in the region."

For further information please visit www.lacpefund.com, or contact:

John West/Andrew Dunn

Tavistock Communications

Tel: 020 7920 3150

Cecilia Wong

London Asia Ltd.

Tel: +852 2251 8373

cecilia.wong@londonasia.com

Helen Goldsmith

Collins Stewart Europe Ltd

Tel: 020 7523 8350

About Asia Clean Energy.

ACE's primary focus is investing in Coal Mine Methane power generating projects, together with other clean renewal energy sources such as wind power and other related technologies.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCFKOKQPBKDOOD
Date   Source Headline
25th Feb 20207:00 amRNSInvestee Company Update: EMMAC Life Sciences
18th Feb 20207:00 amRNSInvestee Company Update: EMMAC Life Sciences
11th Feb 20207:00 amRNSUpdated Key Information Document
31st Jan 20201:30 pmRNSInvestee Company Update: Portage Biotech Inc.
8th Jan 20207:00 amRNSDisposal of Interest in Cryptologic Corp
7th Jan 20207:00 amRNSBoard Appointment
3rd Jan 20201:15 pmRNSInvestee Company Update: Portage Biotech Inc.
11th Dec 20197:00 amRNSHalf-year Report
5th Dec 20192:45 pmRNSTR-1 Notification
19th Nov 20197:00 amRNSLorne Abony appointed as Chairman of EMMAC
16th Oct 20197:00 amRNSInvestee Company Update: EMMAC Life Sciences
15th Oct 20197:00 amRNSInvestee Company Update: Factom inc.
10th Oct 20199:25 amRNSResult of 2019 AGM
27th Sep 20194:31 pmRNSDirector Dealing in the Company
27th Sep 20197:00 amRNSInvestee Company Update : Fralis LLC (Leap Gaming)
26th Sep 201911:21 amRNSInvestee Company Update : Cryptologic Corp
16th Sep 201911:52 amRNSTR-1 Notification of major holdings
11th Sep 20198:00 amRNSResults for the year ended 31st March 2019
11th Sep 20198:00 amRNSNotice of 2019 Annual General Meeting
22nd Aug 201912:01 pmRNSDirectorate Change
19th Aug 20199:23 amRNSJuvenescence closes Series B funding
12th Aug 20193:02 pmRNSInvestee Company Update-Cryptologic issues loan
12th Aug 201910:11 amRNSPortage Trading Suspended
6th Aug 20194:42 pmRNSInvestee Company Update: Cryptologic Corp
30th Jul 201911:07 amRNSSAFE Agreement with Factom, Inc. Extended
25th Jul 20198:17 amRNSFactom Inc SAFE Agreement temporary extension
18th Jul 201911:20 amRNSInvestee Company Update: Regent Pacific on Yooya
16th Jul 20199:13 amRNSInvestee Company Update:EMMAC acquires Terre Verde
11th Jul 20193:00 pmRNSDisposal of interest in Intensity Therapeutics Inc
9th Jul 201910:51 amRNSInvestee Company Update: EMMAC enters new Market
26th Jun 20198:56 amRNSInvestee Company Update: Intensity Therapeutics
29th May 20193:43 pmRNSInvestee Company Update: Offer for Yooya
13th May 201910:21 amRNSDisposal of interest in Vemo Education Inc.
18th Apr 20197:00 amRNSInvestee Company Update: Intensity Therapeutics
4th Apr 20199:51 amRNSTR1 - Correction
3rd Apr 20194:00 pmRNSTR:1 Regent Mercantile Holdings Limited
20th Mar 201911:00 amRNSCompletion of £2 million investment in EMMAC
7th Mar 20194:03 pmRNS£2 million investment in EMMAC Life Sciences
15th Jan 20193:45 pmRNSJuvenescence Series B Funding
3rd Jan 201911:47 amRNSBoard Appointment
12th Dec 201812:52 pmRNSHalf-year Report
3rd Dec 20187:00 amRNSInvestee Company Update: Factom and Yooya
14th Nov 20181:31 pmRNSInvestee Company Update: Factom Inc
22nd Oct 201812:24 pmRNSIntensity Therapeutics Inc Update
12th Sep 20186:12 pmRNSResult of AGM
10th Sep 20189:16 amRNSHolding(s) in Company
22nd Aug 20188:08 amRNSDirector Dealing
3rd Aug 201812:48 pmRNSShareholder update
3rd Aug 20188:00 amRNSPlacing
1st Aug 201812:05 pmRNSResponse to Media Speculation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.